RGT 51.4% 53.0¢ argent biopharma limited

Ann: March Quarterly Activity and Cashflow Report, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,308 Posts.
    lightbulb Created with Sketch. 583
    It's the boards business not shareholders. The cashflows are structured accordingly imo. Openess is an optional extra Roby decides to use at his discretion when it suits.

    For instance Brett takes a 'paycut', compensates it with shares and then just so happens to be getting a 6% cut on 'funds raised'. So, will Brett have actually received less cash from MXC over the past few months, or will the 6% fee more than offset any reduction in wages? Effectively getting more free shares and no reductions in cash received?

    Roby and Brett took a nice 'R&D fee' last qtr through GraftPolymer to ensure personal cashflows remained healthy.... right before they hit MXC holders up for more cash.

    It seems they can't even produce a decent gross profit margin? Won't matter if they bring in $5m revenue in a qtr if it costs 95% of that figure in 'cost of sales'.

    How long before they're putting their hand out to raise more funds? Brett can smell another 6% fee already.




 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.